Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 30, 2017
DARIOHEALTH CORP. ("DARIO") (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced that it intends to offer for sale shares of its common...
-
Mar 30, 2017
DARIOHEALTH CORP. ("DARIO") (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced that it intends to offer for sale shares of its common...
- Mar 27, 2017New strategic alliance with partners expected to increase direct-to-consumer sales
DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it is now offering a 3rd party insurance coverage option...
- Mar 22, 20172016 Revenue Growth of 241% to $2.8 Million
DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the three and twelve month...
- Mar 20, 2017
Earnings and Business Update Conference Call Scheduled for 9:00am ET DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™...
- Mar 2, 2017
Two new board members are Managing Partners at OurCrowd Qure New board members Dr. Yossi Bahagon and Allen Kamer bring unique vision and years of successful digital health executive and...
- Feb 8, 2017DarioHealth to discuss its successful direct-to-consumer strategy and results
DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes meter, today...
- Jan 23, 2017
Direct-to-consumer digital marketing strategy drives 85% sequential increase in U.S. devices sold and 65% increase in consumable sales, quarter-over-quarter DarioHealth Corp. (NASDAQ: DRIO), a...
- Jan 12, 2017
Highlights Deal led by OurCrowd Qure, a dedicated digital health fund that invested $2.5 million of the $5.1 million. Current investors of DarioHealth also participated in the current round...
- Dec 5, 2016Direct-to-consumer approach yields 4,000+ new sign-ups & higher user-engagement results
DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions, announced today that user-engagement metrics were higher during November 2016 when compared to the month...
- Nov 10, 2016Strong consumable and recurring subscription revenues drive quarterly financial results and provide foundation for future growth
DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today reported financial and operational results for the three and nine month periods ended September...
- Nov 7, 2016Earnings and Business Update Conference Call Scheduled for 9:00am EST
DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes meter, announced...
- Oct 25, 2016More than 10,000 Dario smart meters sold in the U.S.
DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes meter, today...
- Sep 27, 2016Collaborative partnership with A&D Medical and Diabetes Express to expand distribution of Dario in Canada with online platform for sales and prescription processing
DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution, today announced the launch of an...
- Sep 8, 2016Agility to Navigate Complex Mobile Ecosystem Showcases DarioHealth's Versatility
DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced that it is adapting its flagship product to also incorporate use with the new Apple®...
- Aug 11, 2016Revenues More than Double Year-over-Year;
DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today reported financial and operational results for the three and six month period ended June 30,...
-
Jul 28, 2016Broader Reach via Digital Marketing Strategy Higher Product Margins
DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario(TM) Smart Diabetes Management Solution, today announced that it has begun...
-
Jul 27, 2016Company Announces Corporate Name Change to DarioHealth Corp. to Reflect Expansion of Comprehensive Digital Health and Lifestyle Offering
Labstyle Innovations Corp. (NASDAQ: DRIO) - a leader in digital health and mobile health solutions - announced today that it is changing its corporate name to DarioHealth Corp. The name change...
-
Jul 21, 2016Expands Reach to Pharmacies and Durable Medical Dealers Access on Commercial Health Plans
LabStyle Innovations Corp. (NASDAQ:DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today that it has signed an agreement with GEMCO Medical, an established healthcare...
-
Jul 19, 2016Direct-to-Consumer Digital Marketing Strategy Driving Rapid Initial Market Penetration
LabStyle Innovations (NASDAQ: DRIO) - a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution - today announced that since the...
-
Jul 11, 2016Dario Smart Diabetes Management Solution to reach thousands of college students across the U.S.
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced it has joined the College Diabetes Network (CDN) as a Corporate Member. Since its...
-
May 27, 2016
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that the Company's Chief Financial Officer, Zvi Ben-David will present at the Marcum...
-
May 11, 201684% increase in sequential quarterly revenues
Quarterly gross loss narrowed 61% compared to Q4 2015 Net loss narrowed by 29% compared to Q4 2015 Launched Dario Blood Glucose Monitoring System in the United States late in the first quarter...
-
May 5, 2016
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that it has been granted a key patent by the European Patent Office (EPO) for the...
-
Mar 23, 2016
ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times...
-
Mar 15, 2016World's largest glucose monitoring market gets user-centric mHealth product that brings diabetes management into the digital age
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the national availability of Dario in the U.S. The U.S. rollout follows the...
-
Mar 9, 2016Broadens platform technology's applications beyond mHealth and into health and non-health related industrial markets
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038...
-
Mar 4, 2016Company Effects a 1-for-18 Reverse Stock Split
LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective...
-
Feb 9, 2016- FDA clearance announced on December 22nd
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and operational results for the year ended December 31, 2015 and provided an...
-
Jan 26, 2016- Sales channels to include direct-to-consumer, e-commerce, third-party distributors
CAESAREA, Israel / LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the...
-
Dec 22, 2015Smartphone-based blood glucose monitor with unique all-in-one design cleared for launch in the world's largest diabetes market
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that the United States Food and Drug Administration (FDA) has granted 510(k)...
-
Dec 16, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced its personalized smart blood glucose meter has recently been featured in numerous...
-
Nov 19, 2015A LabStyle distributor participated in the investment
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it has closed on an offering raising approximately $2.3 million in proceeds...
-
Nov 16, 2015Mobile healthcare apps and social media become platform for user-centric revolution enabling people to take charge of their health
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that Facebook (NASDAQ:FB) published a case study about the Company's social media...
-
Nov 13, 2015- 56% increase in sequential quarterly revenues
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today reported financial and operational results for the three months ended September 30, 2015 and...
-
Nov 11, 2015Centaur, one of India's leading healthcare companies, to offer Dario in a region where over 66 million people live with diabetes
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, announced today that it has signed an exclusive distribution agreement with one of India's leading...
-
Oct 29, 2015LabStyle Innovations Reports Dario Blood Glucose Monitor Demonstrates Over 99% Accuracy in New StudyReported in poster presentation at Diabetes Technology Meeting on October 22 and 23, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced results from a recent performance accuracy study of the Dario™ Blood Glucose...
-
Oct 15, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced Dr. Paul Rosman, who serves on the Company's Scientific Advisory Board, will...
-
Oct 12, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced its Medical Director, Dr. Moshe Kamar, will present a patient case study at...
-
Sep 30, 2015Todd Durniak to demonstrate the Dario solution during the breakout session "The Measured Life: Tracking from Head to Toe"
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that its Executive Vice President of U.S. Operations, Todd Durniak, will deliver a...
-
Sep 17, 2015Medical and tech industry publications interview Exec V.P. of U.S. Operations, Todd Durniak
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced the Dario has recently been featured in numerous U.S.-based media outlets...
-
Sep 9, 2015Mobile health technology market projected to reach $8 billion by 2018
LabStyle Innovations Corp. (OTCQB: DRIO), today announced it has been granted a patent from the U.S. Patent and Trademark Office for U.S. Patent No. 9,125,549 on September 8, 2015. The patent...
-
Sep 3, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced the Company will present at the Rodman & Renshaw 17th Annual Global Investment...
-
Aug 31, 2015Investors include company officers, employees, friends & family; Participating high net worth private investors include current shareholders and a new investment by Shmuel Farhi
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds...
-
Aug 25, 2015Dario Diabetes Management Solution is very well received in Australian market following recent regulatory and reimbursement approvals
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that in conjunction with its Australian distributor, uHealth, the Company is...
-
Aug 13, 2015-- 161% jump in sequential quarterly revenues
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today reported financial and operational results for the three-month period ended June 30, 2015,...
-
Jul 29, 2015Benefits of the recently launched Dario highlighted nationwide to Australian viewers
LabStyle Innovations Corp. (DRIO), today announced that its Dario™ Diabetes Management Solution was featured in a national broadcast news segment in Australia. The Dario was recently launched in...
-
Jul 22, 2015Q&A with Managing Editor includes in-depth interview about LabStyle's leadership in the diabetes and digital health industries
LabStyle Innovations Corp. (DRIO), today announced that its President & CEO Erez Raphael is featured on the cover of the July 21issue of Opportunist Magazine. In the feature article Raphael talks...
-
Jul 14, 2015Insurance claims for the Dario Test Strips to be reimbursed in Canada
LabStyle Innovations Corp. (DRIO), today announced the Dario™ Diabetes Management Solution's Smart Meter test strips are now reimbursed in Canada by most private insurance plans after the...
-
Jul 1, 2015Todd Durniak brings deep industry expertise in diabetes and medical device industry, with track record of successful product launches
LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced the appointment of Todd Durniak as Senior Vice President and General Manager for the U.S....
